From Gilead Adds “Cornerstone” Cancer Drug in $21B Immunomedics Buyout:

Corner stone

Corner stone—

Image: iStock/Darrin Hughes
https://www.istockphoto.com/portfolio/darrinhughes?assettype=image&mediatype=photography&sort=best

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!